Table 1 Relationship between clinicopathologic characteristics and STEAP3 protein expression in OC.
From: Identification of STEAP3-based molecular subtype and risk model in ovarian cancer
Characteristics | N | STEAP3, n (%) | χ2 | P value | |
|---|---|---|---|---|---|
Low | High | ||||
Age (year) | Â | Â | Â | Â | Â |
≤ 52 | 60 | 36 (60.0) | 24 (40.0) | 3.910 | 0.048 |
> 52 | 51 | 21 (41.2) | 30 (58.8) |  |  |
Stage | Â | Â | Â | Â | Â |
I-II | 52 | 37 (71.2) | 15 (28.8) | 15.356 | < 0.001 |
III-IV | 59 | 20 (33.9) | 39 (66.1) | Â | Â |
Grade | Â | Â | Â | Â | Â |
Low | 30 | 20 (66.6) | 10 (33.3) | 3.860 | 0.049 |
High | 81 | 37 (45.7) | 44 (54.3) | Â | Â |
Type | Â | Â | Â | Â | Â |
Serous carcinoma | 78 | 38 (48.7) | 40 (51.3) | 0.728 | 0.393 |
Others | 33 | 19 (57.6) | 14 (42.4) | Â | Â |
LVSI | Â | Â | Â | Â | Â |
Negative | 84 | 49 (58.3) | 35 (41.7) | 6.739 | 0.009 |
Positive | 27 | 8 (29.6) | 19 (70.4) | Â | Â |
LNM | Â | Â | Â | Â | Â |
Negative | 80 | 49 (61.3) | 31 (38.8) | 11.235 | 0.001 |
Positive | 31 | 8 (25.8) | 23 (74.2) | Â | Â |